Search

everythinglearnresearchcommunity

for

Search:↓

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

Low-level laser therapy is safe and can increase hair growth for male and female pattern hair loss.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Prostaglandin D₂ might be targeted for new male pattern baldness treatments.

Improving the environment and cell interactions is key for creating human hair in the lab.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Some dermatological medications can impair male fertility, so consult a doctor before trying to conceive.

Research on epidermal stem cells has advanced significantly, showing promise for improved clinical therapies.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

Antidepressants, 5α-reductase inhibitors, and isotretinoin can cause long-lasting sexual dysfunction.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Finasteride can reduce fertility in some men, but stopping it increases sperm count.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Hair loss in women may have causes other than hormones.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Certain drugs that block specific enzymes can help treat prostate diseases.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

Low doses of mixed chemicals cause permanent reproductive malformations in male rats.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

The combination of cyproterone acetate and testosterone enanthate is highly effective in preventing sperm production and could be a good reversible male contraceptive.

Finasteride-loaded nanoparticles may help treat alopecia.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.